IRC
AIMT

Investors Research Corp’s Aimmune Therapeutics AIMT Stock Holding History

Investors Research Corp’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$2K – 1132
2020
Q3 		$2K Hold
50
– – ﹤0.01% 1021
2020
Q2 		$1K Hold
50
– – ﹤0.01% 1074
2020
Q1 		$1K Buy
+50
New +$1.28K ﹤0.01% 1103

Investors Research Corp's AIMT Position: Q4 2020 in Review

Investors Research Corp sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 50 shares — an estimated $2K sold.

Investors Research Corp first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $2K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Investors Research Corp reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Investors Research Corp sold 50 Aimmune Therapeutics shares in Q4 2020, an estimated $2K.
  • Investors Research Corp first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
  • Investors Research Corp's Aimmune Therapeutics position peaked at $2K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Investors Research Corp's 13F filing for Q4 2020, filed 21 Jan 2021.